@business It’s an old study https://t.co/QOtQ7PftrJ
@60dcito @OtraPendeja sii obvio, no voy a tratar de convencer a nadie pero hay muchísimos estudios científicos (y de hecho ya se esta probando en personas), dejo un estudio bastante completo https://t.co/xz69O4zEj7 y hay muchos más info https://t.co/7ECPR
תרופות דיכאון מקובלות. זאת במקביל לעובדה שאין לפסילוציבין שום אפקט שלילי פזיולוגי (בניגוד לתרופות הדיכאון הקיימות). ופה אני נאלץ לאכול את הכובע מהפוסט הקודם. נכון להיום (ונעשה כבר לא מעט מחקר בנושא) אין שום השפעה שלילית פזיולוגית לא לטווח קצר ולא לטווח->
@EikoFried I think there are a lot of studies that show very positive results, they vary in their construction, I agree, but I think it's difficult to remain entirely sceptical. What about this one: https://t.co/jxFIKWR0BD
RT @LukeJelen: @PhilCorlett1 @m_wall LP: first 12 open-label participants (QIDS) Psychopharmacology (https://t.co/wRq5pHLe8q) : final 19 op…
@PhilCorlett1 @m_wall LP: first 12 open-label participants (QIDS) Psychopharmacology (https://t.co/wRq5pHLe8q) : final 19 open-label participants (QIDS) Sci Rep: (same) 19 open-label participants (QIDS) Nat. med.: (same) 19 open-label participants + those
@DJSicFanny @TheDailyShroom I wouldnt say there’s no evidence, there’s just not very much evidence yet. This study showed it helped some people with long-standing depression, and there was a TV documentary where people talked about their experiences with
A study of patients with treatment-resistant depression who underwent #psilocybin treatment shows promising results, with rapid alleviation of symptoms which remained significant at 3 and 6 month follow-ups. https://t.co/ZkoPhwJMDr
@xoo_roos خب FDA بیشتر از اینکه یک نهاد تحقیقاتی باشه، یک نهاد قانونیه. و سیاست هم روی تصمیمات اون بیتأثیر نیست. در ضمن، فرآیند تایید FDA بسیار طولانیه و بعضن تا ۱۰ سال طول میکشه. https://t.co/WYmrIZGTp2 https://t.co/GKEaV3RD9X https://t.co/nvktepcrV8
RT @recover2renew: @DuthieAlyne Yeah ... The gang of 🍄🍄pushers ... https://t.co/QMKlbJdkV1
@DuthieAlyne Yeah ... The gang of 🍄🍄pushers ... https://t.co/QMKlbJdkV1
RT @lonnibesancon: A pretty cool article here on the effect of magic mushrooms on depression from @rachelschraer. Too bad the article doesn…
RT @lonnibesancon: A pretty cool article here on the effect of magic mushrooms on depression from @rachelschraer. Too bad the article doesn…
A pretty cool article here on the effect of magic mushrooms on depression from @rachelschraer. Too bad the article doesn't link to the study itself though. Previous research was already conducted on this: https://t.co/mNzuaaiX8r https://t.co/8PLSsCOYKb htt
@jcthemd @LetiLagertha @FitzgeraldSTA Here many people do this. Works great! https://t.co/X9Oh7DI7KI
@clarkflavor @JHPsychedelics @JAMAPsych See for instance https://t.co/gjiXG0NHOs
@aleshammah Hay un follow up más actual https://t.co/T0NatTrvmJ
@VickyFieldsGC sí suena a pseudociencia pero... "Psilocybin represents a promising paradigm for unresponsive depression" https://t.co/7kGxsUaciA Y como este estudio hay muchos que ven a la psilocibina como una gran herramienta para la salud mental.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/oiKWIp96fD @BeckleyResearch @RCarhartHarris @TheDailyShroom https://t.co/JrIVZIGuWl
RT @LiquidLifeBC: As stated in a 2018 study published in Psychopharmacology, "Psilocybin represents a promising paradigm for unresponsive d…
RT @LiquidLifeBC: As stated in a 2018 study published in Psychopharmacology, "Psilocybin represents a promising paradigm for unresponsive d…
As stated in a 2018 study published in Psychopharmacology, "Psilocybin represents a promising paradigm for unresponsive depression..." 🍄🍄🍄 #MagicMushrooms #Mushrooms #Psilocybin https://t.co/VXUq8JwTLs
@bIondiewasabi research about using psilocybin (shrooms) for treatment-resistant depression has had extremely promising results, bad take dude https://t.co/1kJRNDCe5l https://t.co/r92pawd3Aw
Read this study on the use of Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/SNngevdMGT #psilocybin #mentalhealth #depression
Interesting food for thought 💭 🤍 Here’s some peer reviewed research in support👇🏾 “Psilocybin represents a promising paradigm for unresponsive depression that warrants further research in double-blind randomised control trials.” https://t.co/99BKjHpjOP
"Magic mushrooms" for TRD? Psilocybin With Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up https://t.co/lWJGiGJJ7o
The Cure Is Near. https://t.co/tYrSAUI3YH
@hazelinha Es mucho mejor la psilocibina https://t.co/6Cge4AiZL7
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. - PubMed - NCBI https://t.co/S69ujnmOg9
@sheldonbailey @obsteve1 @BaDorfman There’s a lot written on the use of psilocybin out there. https://t.co/d9o9gHhvMd
Psicoterapia com auxílio de cogumelos com psilocibina já é reconhecidamente o melhor tratamento contra depressões resistentes. https://t.co/M5HSu93cqL
Spännande forskning om psilocybin som behandling mot depression. Hoppas studier om psykedeliska droger snart tillåts i Sverige.
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT briandavidearp: RT briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.co/9WLa0s7iab
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT @JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2…
RT @JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2…
RT @JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2…
RT @JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2…
RT briandavidearp: RT JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/tmAbVhxKu9 ht briandavidearp
RT @JustinCaouette: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2…
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/6AcrNwlSf2 ht @briandavidearp
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT @briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.…
RT briandavidearp: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.co/9WLa0soTyL
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up | SpringerLink https://t.co/XlasicYTOL
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up https://t.co/TrmcvIG5l0
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/xyzrFKpCz9
RT @maboroshin: シロシビンでは、脳のネットワークの仕方が右図のように、変則的で密になる。うつでは平均して重症が軽症になる。https://t.co/aF0l05jUZB強迫症状は効いてる時には止まる(こっちは体験中に治っているけど、体験後にも治ってしまう人は少な…
RT @maboroshin: シロシビンでは、脳のネットワークの仕方が右図のように、変則的で密になる。うつでは平均して重症が軽症になる。https://t.co/aF0l05jUZB強迫症状は効いてる時には止まる(こっちは体験中に治っているけど、体験後にも治ってしまう人は少な…
@gordocontrapo Coge con escepticismo lo que te voy a decir: psilocibina Los estudios están aún en pañales, pero te dejo uno https://t.co/QtDhhvSTGI
RT @psychopharmacol: open label study: psilocybin-assisted psychotherapy for treatment-resistant depression exhibited good tolerability wit…
RT @psychopharmacol: open label study: psilocybin-assisted psychotherapy for treatment-resistant depression exhibited good tolerability wit…
open label study: psilocybin-assisted psychotherapy for treatment-resistant depression exhibited good tolerability with effect sizes large (Cohen’s d = 2.2 at week 1 and 2.3 at week 5) and remained significant 6 months post-treatment https://t.co/gSwhO1cue
Srsly tho these things are psychiatric supernovae (https://t.co/KO2fEgh01H) https://t.co/1SKftqWVXO
@ryebur @ProfDavidNutt And another: https://t.co/g0ofPWKCWg
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/eqEuSjYfwr
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
RT @BeckleyResearch: 2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom impro…
2017 Highlights: Beckley/Imperial psilocybin for depression study published a 6 month follow-up, showing symptom improvements sustained for up to 6 months https://t.co/fpTjw9UaC6
RT @findevan: 🍄🍄🍄 Help for those with treatment resistant depression is coming from psilocybin mushrooms. Small study, but powerful result…
RT @findevan: 🍄🍄🍄 Help for those with treatment resistant depression is coming from psilocybin mushrooms. Small study, but powerful result…
RT @findevan: 🍄🍄🍄 Help for those with treatment resistant depression is coming from psilocybin mushrooms. Small study, but powerful result…
🍄🍄🍄 Help for those with treatment resistant depression is coming from psilocybin mushrooms. Small study, but powerful results! ✌🏼❤️🍄🚀 https://t.co/axnjNvSabe
RT @Imperial_PRG: Important publication from our group. Full clinical results from our psilocybin for depression trial: #psychedelics #depr…
Antidepressants linked to mass shootings: https://t.co/vY5IYH566L Psychedelics treat depression, reduce risk of suicide: https://t.co/SnlvySJ1Ei, https://t.co/mCZbsHwXEb One is prescription medication, one is illegal. Funny how that works.
RT @HeadsNews: Study: "Psilocybin with psychological support for treatment-resistant depression: 6-month follow-up" by @Imperial_PRG. https…
Study: "Psilocybin with psychological support for treatment-resistant depression: 6-month follow-up" by @Imperial_PRG. https://t.co/8GFPIwGCyY https://t.co/wVXfHjIOVW
RT @Imperial_PRG: Important publication from our group. Full clinical results from our psilocybin for depression trial: #psychedelics #depr…
From the 8th of November, Enjoy. #Legalize #Psilocybin #depression https://t.co/FXSOWc8AiT
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/CxU7KxRiCb
RT @OxPsychiatry: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/XRZT9kl3W3
RT @OxPsychiatry: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/XRZT9kl3W3
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. https://t.co/XRZT9kl3W3
RT @Imperial_PRG: Important publication from our group. Full clinical results from our psilocybin for depression trial: #psychedelics #depr…
RT @Imperial_PRG: Important publication from our group. Full clinical results from our psilocybin for depression trial: #psychedelics #depr…
RT @Imperial_PRG: Important publication from our group. Full clinical results from our psilocybin for depression trial: #psychedelics #depr…